In Segment A, participants will acquire distinct doses and schedules of oral ABBV-744 pill to detect Safe and sound dosing regimen. Additional contributors will likely be enrolled within the recognized monotherapy dosign program. In Segment B, contributors will get oral ruxolitinib and ABBV-744 will probably be presented as "include-on" therapy. https://emperorw110itd2.muzwiki.com/user